Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Ann Clin Lab Sci ; 54(3): 419-422, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-39048165

RESUMO

OBJECTIVE: Familial hypercholesterolemia (FH) is characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C) and cardiovascular disease (CVD). Although the role of LDL-C in FH has been studied, the contribution of high-density lipoproteins (HDL) to CVD in FH remains unknown. This study aimed at highlighting the role of HDL in FH. METHODS: HDL-specific phospholipid efflux (HDL-SPE) assay was developed to predict CVD risk. HDL-SPE was examined in FH patients (n=30) and compared with age- and sex-matched non-FH controls (n=60). RESULTS: FH patients had significantly lower HDL-SPE levels (0.90±0.12) than controls (1.12±0.10; p<0.05), despite similar HDL-cholesterol levels in both groups (FH: 57.9±18.7 mg/dl; controls: 57.1±13.8 mg/dl). These differences remained significant after adjusting for confounders. CONCLUSIONS: These findings suggest there may be dysfunctionality of HDL in FH.


Assuntos
Hiperlipoproteinemia Tipo II , Lipoproteínas HDL , Fosfolipídeos , Humanos , Hiperlipoproteinemia Tipo II/sangue , Hiperlipoproteinemia Tipo II/metabolismo , Masculino , Feminino , Lipoproteínas HDL/metabolismo , Lipoproteínas HDL/sangue , Adulto , Fosfolipídeos/metabolismo , Fosfolipídeos/sangue , Pessoa de Meia-Idade , Estudos de Casos e Controles , HDL-Colesterol/sangue , HDL-Colesterol/metabolismo , Doenças Cardiovasculares/metabolismo , Doenças Cardiovasculares/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA